Notes - Segment Information, Etc.

KYORIN Pharmaceutical Co., Ltd. - Filing #7710952

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
113,620,000,000 JPY
107,859,000,000 JPY
5,761,000,000 JPY
JPY
113,620,000,000 JPY
110,640,000,000 JPY
104,703,000,000 JPY
5,937,000,000 JPY
110,640,000,000 JPY
JPY
Transactions with other segments
13,000,000 JPY
12,000,000 JPY
0 JPY
-13,000,000 JPY
JPY
JPY
14,000,000 JPY
0 JPY
14,000,000 JPY
-14,000,000 JPY
Other items
Depreciation
2,691,000,000 JPY
2,654,000,000 JPY
37,000,000 JPY
249,000,000 JPY
2,940,000,000 JPY
3,644,000,000 JPY
3,285,000,000 JPY
52,000,000 JPY
3,338,000,000 JPY
306,000,000 JPY
Investments in entities accounted for using equity method
625,000,000 JPY
625,000,000 JPY
JPY
JPY
625,000,000 JPY
603,000,000 JPY
603,000,000 JPY
JPY
603,000,000 JPY
JPY
Increase in property, plant and equipment and intangible assets
4,362,000,000 JPY
4,316,000,000 JPY
46,000,000 JPY
55,000,000 JPY
4,418,000,000 JPY
3,541,000,000 JPY
3,413,000,000 JPY
29,000,000 JPY
3,443,000,000 JPY
98,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.